We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$14.4B
AUM Growth
+$3.17B
Cap. Flow
+$1.99B
Cap. Flow %
13.87%
Top 10 Hldgs %
75.34%
Holding
1,511
New
483
Increased
305
Reduced
301
Closed
405

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$92.1M
2
MSFT icon
Microsoft
MSFT
+$81.2M
3
NVDA icon
NVIDIA
NVDA
+$77.3M
4
LLY icon
Eli Lilly
LLY
+$27.2M
5
SPOT icon
Spotify
SPOT
+$27.1M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$59M
2
AAPL icon
Apple
AAPL
+$50.2M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$33.8M
4
UNH icon
UnitedHealth
UNH
+$21.4M
5
SMCI icon
Super Micro Computer
SMCI
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Financials 2.03%
3 Industrials 1.57%
4 Healthcare 1.55%
5 Communication Services 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFE icon
151
CALL
New Fortress Energy
NFE
$101M
$3.95M 0.03%
435,000
+370,000
+569% +$5.71M
CAH icon
152
Cardinal Health
CAH
$55.4B
$3.94M 0.03%
35,681
+27,151
+318% +$2.84M
CNX icon
153
CNX Resources
CNX
$5.2B
$3.83M 0.03%
+117,680
New +$3.17M
BDX icon
154
Becton Dickinson
BDX
$48.2B
$3.82M 0.03%
15,834
+2,066
+15% +$484K
ADP icon
155
Automatic Data Processing
ADP
$108B
$3.77M 0.03%
+13,638
New +$3.57M
TMO icon
156
Thermo Fisher Scientific
TMO
$220B
$3.72M 0.03%
6,007
-18,333
-75% -$10.9M
UAL icon
157
PUT
United Airlines
UAL
$42.1B
$3.71M 0.03%
65,000
+5,000
+8% +$231K
BIO icon
158
Bio-Rad Laboratories Class A
BIO
$9.42B
$3.71M 0.03%
11,083
+8,825
+391% +$2.8M
MMM icon
159
3M
MMM
$94.3B
$3.56M 0.02%
26,062
+14,746
+130% +$1.81M
ROKU icon
160
Roku
ROKU
$22.7B
$3.54M 0.02%
47,458
+32,511
+218% +$2.08M
ECHO
161
PUT
EchoStar
ECHO
$26.2B
$3.47M 0.02%
140,000
-288,000
-67% -$5.89M
DG icon
162
Dollar General
DG
$27.9B
$3.47M 0.02%
+40,989
New +$4.49M
PG icon
163
Procter & Gamble
PG
$339B
$3.45M 0.02%
+19,907
New +$3.38M
SRCL
164
DELISTED
Stericycle Inc
SRCL
$3.44M 0.02%
+56,439
New +$3.35M
VRTX icon
165
Vertex Pharmaceuticals
VRTX
$126B
$3.44M 0.02%
7,389
+2,965
+67% +$1.42M
ACM icon
166
Aecom
ACM
$9.75B
$3.43M 0.02%
33,183
+8,307
+33% +$780K
LDOS icon
167
Leidos
LDOS
$17.3B
$3.42M 0.02%
20,994
+828
+4% +$125K
AMAT icon
168
Applied Materials
AMAT
$428B
$3.36M 0.02%
+16,609
New +$3.41M
KEY icon
169
KeyCorp
KEY
$24.4B
$3.35M 0.02%
+200,002
New +$3.17M
REGN icon
170
Regeneron Pharmaceuticals
REGN
$80.8B
$3.35M 0.02%
+3,184
New +$3.54M
ADM icon
171
Archer Daniels Midland
ADM
$36.9B
$3.34M 0.02%
55,900
-27,614
-33% -$1.68M
VLO icon
172
Valero Energy
VLO
$85.9B
$3.32M 0.02%
24,578
-11,276
-31% -$1.64M
TJX icon
173
TJX Companies
TJX
$178B
$3.27M 0.02%
27,808
-10,628
-28% -$1.22M
ABT icon
174
Abbott
ABT
$187B
$3.26M 0.02%
28,573
-2,602
-8% -$285K
UPST icon
175
Upstart Holdings
UPST
$3.03B
$3.22M 0.02%
80,567
+41,904
+108% +$1.39M
5 6
7
8 9

Similar funds

GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Brevan Howard Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Brevan Howard Capital Management held 1,511 positions worth $14.4B, up 28% from $11.2B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Brevan Howard Capital Management deployed $1.99B of net new capital in Q3 2024, opening 483 new positions and adding to 305 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $21.4M trimmed.

  • Brevan Howard Capital Management's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.
  • Brevan Howard Capital Management added most to Eli Lilly in Q3 2024, an estimated $27.2M increase.
  • Brevan Howard Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $21.4M.
  • Brevan Howard Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, selling an estimated $59M.
  • Brevan Howard Capital Management's ten largest holdings make up 75% of its $14.4B portfolio in Q3 2024.
  • Brevan Howard Capital Management opened 483 new positions and closed 405 in Q3 2024.
  • Brevan Howard Capital Management's portfolio value rose 28% quarter-over-quarter to $14.4B.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.